Two vs three cycles of neoadjuvant sintilimab plus chemotherapy for resectable non-small-cell lung cancer: neoSCORE trial.

ABSTRACT:

SUBMITTER: Shao M 

PROVIDER: S-EPMC10083171 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature